Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism

National Medical Journal of China

Volumn 87, Issue 43, 2007, Pages 3074-3078

  Pang, Bao Sen ^a   Wang, Chen ^a   Lu, Yong ^a   Yang, Yuan Hua ^a   Xing, Guo Hong ^a   Mao, Yan Ling ^a   Huang, Xiu Xia ^a   Zhai, Zhen Guo ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Anticoagulants; Endothelium, vascular; Pulmonary embolism; Thrombolytic, therapy

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; D DIMER; FIBRINOLYTIC AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMAN; LUNG EMBOLISM; MALE; PROTEIN BLOOD LEVEL; VASCULAR ENDOTHELIUM;

ACUTE DISEASE; AGED; ANTICOAGULANTS; BLOOD COAGULATION; ENDOTHELIUM, VASCULAR; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 38849124225     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Chinese source.
2. De Monyé W, Sanson BJ, Mac Gillavry MR, et al. Embolus location effects the sensitivity of a rapid guantitative D-dimer as in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med, 2002, 165:345-348.
3. Mavromatis BH, Kessler CM. D-dimer testing: the role of the clinical laboratory in the diagnosis of pulmonary embolism. J Clin Pathol, 2001, 54:664-668.
4. Brown MD, Rowe BH, Reeves MJ, et al. The accuracy of the enzyme-linked immunosorbent assay D-dimer test in the diagnosis of pulmonary embolism: a meta-analysis. Ann Emerg Med, 2002, 40:133-144.
5. Perrier A, Bounameaux H. Cost-effective diagnosis of deep vein thrombosis and pulmonary embolism. Thromb Haemost, 2001, 86:475-487.
6. Chinese source.
7. Margaglione M, Brancaccio V, De Lucia D, et al. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest, 2000, 118:1405-1411.
8. Watanabe R, Wada H, Sakakura M, et al. Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states. Am J Hematol, 2000, 65:35-40.
9. Yamada N, Wads H, Nakase T. Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis. Blood Coagul Fibrinolysis, 1995, 6:627-633.
10. Flores J, Garcia-Avello A, Flores VM, et al. Tissue plasminogen activator plasma levels as a potential diagnostic aid in acute pulmonary embolism. Arch Pathol Lab Med, 2003, 127: 310-315.
11. Palla A, Bellina CR, Marina C, et al. A non-invasive, quantitative method to demonstrate the early effects of therapy in acute pulmonary embolism. Eur J Nucl Med 2001, 28: 1605-1609.